New sedative may cut delirium risk in ventilated kids
NCT ID NCT07542990
First seen Apr 29, 2026 · Last updated Jun 02, 2026 · Updated 7 times
Summary
This study tests whether dexmedetomidine, a sedative, can lower the chance of delirium (sudden confusion) in children who need a breathing machine in the ICU. About 266 children aged 1 month to 17 years will be randomly assigned to receive either dexmedetomidine or the standard drug midazolam. The main goal is to see if fewer children experience delirium with dexmedetomidine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM IN THE INTENSIVE CARE UNIT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU d'Angers
Angers, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Caen
Caen, 14033, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Lille
Lille, 59120, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Marseille
Marseille, 13385, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nantes
Nantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Strasbourg
Strasbourg, 67200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Tours
Tours, 37000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.